Search Results 421-430 of 19486 for alzheimers

1. Faculty and staff - Alzheimer's Disease Research Center - Mayo Clinic Research

   A multidisciplinary faculty guides research in the Mayo Clinic Alzheimer's Disease Research Center.

2. Alzheimer's disease - Doctors and departments - Mayo Clinic

   Understand more about this brain disease that is the most common cause of dementia. Also learn about new tests and medicines.

3. New Alzheimer's drug to be submitted to FDA for approval - Mayo Clinic News Network

   Ronald Petersen, director of the Alzheimer's Disease Research Center at Mayo Clinic, says aducanumab targets the amyloid plaques in the brain that are believed ...

4. Faculty and staff - Alzheimer's Disease Research Center - Mayo Clinic Research

   A multidisciplinary faculty guides research in the Mayo Clinic Alzheimer's Disease Research Center.

5. How is artificial intelligence helping to diagnose dementia? - Mayo Clinic

   If the scan shows reduced sugar use in the areas of the brain involved in solving problems and remembering, for example, that can be an indicator of Alzheimer's ...

6. Mitochondria vs. Alzheimer's - Mayo Clinic News Network

   Eugenia Trushina, Ph.D., is leading basic science research that could someday lead to solutions for people with Alzheimer's. Targeting mitochondria is a ...

7. Medical Research & Education - Mayo Clinic News Network

   Researchers have developed a new tool that can estimate a person's risk of developing memory and thinking problems associated with Alzheimer's disease years ...

8. Mayo Clinic Alzheimer's researcher hopeful, despite new drug's failure

   The trial used Eli Lilly's drug solanezumab, an antibody, to try to target the building blocks of amyloid plaques in the brains of the those with Alzheimer's.

9. Mika Cadiz: Examining Effects of New Drugs for Alzheimer’s Disease - Student Research - Mayo Clinic College of Medicine & Science

   Mika Cadiz, Ph.D. student in the Neuroscience track at Mayo Clinic, shares research on the effects of new drugs for Alzheimer's disease.

10. A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

    mild Alzheimer's disease according to National Institute on Aging and Alzheimer's Association (NIA-AA) criteria: 1. Have an MMSE score between 22 and 30 ...